The appropriate localization of regulatoryT (TReg) cells is important to ensure that they suppress any unwanted or over-exuberant immune response. But how important is TReg cell migration to the draining lymph nodes (DLNs) versus the inflamed tissue or transplanted graft for their function? Bromberg and colleagues now show that TReg cells sequentially migrate from inflamed tissues to the DLN in an islet allograft model and that this migration pattern is necessary for the optimal suppressive function of TReg cells and islet graft survival.

To examine the migration of TReg cells to a site of inflammation and/or DLNs, the authors intravenously transferred TReg cells into mice with an islet allograft (which was inflamed owing to the alloreactive T cell response) and found that TReg cells migrated to both the islet graft and the DLN, as expected. The authors then intravenously transferred TReg cells that did not express specific CC-chemokine receptors (CCRs) or selectins that are known to have a role in TReg cell migration. They found that migration from the blood to the islet graft required the expression of E-selectin and P-selectin, CCR2, CCR4 and CCR5. By contrast, migration to the DLN required the expression of CCR7 and L-selectin. Of interest, TReg cells that could migrate to the islet graft but not the DLN prolonged graft survival, whereas TReg cells that could migrate to the DLN but not the islet graft did not prolong graft survival. This indicates that TReg cell migration to the islet graft is required for its survival.

The local transfer of TReg cells to the same site as the islet graft resulted in higher numbers of TReg cells in the DLN compared with intravenous transfer, suggesting that TReg cells migrate from the graft to the DLN. This process was shown to require the expression of CCR2, CCR5 and CCR7. In addition, the local transfer of TReg cells further prolonged graft survival compared with intravenously transferred TReg cells. However, TReg cells that could not migrate to the DLN after local transfer did not further prolong graft survival, indicating that TReg cell migration from the islet graft to the DLN, in addition to migration to the islet graft, is necessary for optimal TReg cell function.

By comparing graft survival following local transfer of wild-type or Ccr7−/− TReg cells (which are excluded from the DLN) and intravenous transfer of wild-type or Ccr2−/− TReg cells (which are excluded from the islet graft), the authors showed that optimal graft survival required the sequential migration of TReg cells from the islet graft to the DLN. This sequential migration was necessary for the activation and differentiation of TReg cells that produced interleukin-10 (IL-10), transforming growth factor-β (TGFβ) and granzyme B.

Finally, the authors showed that TReg cells in the islet graft inhibited the migration of dendritic cells from the islet graft to the DLN in an IL-10- and TGFβ-dependent manner. TReg cells also inhibited the migration, accumulation and proliferation of effector T cells at both sites in an IL-10-dependent manner, but optimal suppression required the sequential migration of the TReg cells.

So, this study shows that the migration of TReg cells to islet grafts is required for allograft survival but that the sequential migration of TReg cells from the islet graft to the DLN is required for optimal TReg cell suppression and inhibition of effector T cell responses.